VolitionRX Ltd (NYSE American:VNRX)

0.761
Delayed Data
As of Sep 25
 +0.0679 / +9.80%
Today’s Change
0.63
Today|||52-Week Range
2.74
-68.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$54.2M

Company Description

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

Contact Information

VolitionRX Ltd.
1489 West Warm Springs Road
Henderson Nevada 89014
P:(646) 650-1351
Investor Relations:
1646

Employees

Shareholders

Other institutional6.61%
Individual stakeholders24.16%
Mutual fund holders1.65%

Top Executives

Cameron John ReynoldsPresident, Chief Executive Officer & Director
Gaetan MichelChief Operating Officer
Terig HughesChief Financial Officer & Treasurer
Jacob Vincent MicallefChief Scientific Officer
Mark EcclestonChief Technology Officer